Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
31 hedge funds and large institutions have $34.2M invested in Apollo Endosurgery, Inc. in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 8 closing their positions.
140% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
15% more capital invested
Capital invested by funds: $29.7M → $34.2M (+$4.53M)
11% less funds holding
Funds holding: 35 → 31 (-4)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.38M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$525K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$292K |
| 4 |
Goldman Sachs
New York
|
+$120K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$59.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$273K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$177K |
| 3 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
-$69K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$41.6K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$15.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $5K | -$11.3K | -3,220 | -70% |
|
|
VFA
27
Valeo Financial Advisors
Carmel,
Indiana
| $1K | – | – | – |
|
28
Barclays
London,
United Kingdom
| $1K | +$1.24K | +353 | New |
|
|
RE
29
RBC Europe
London,
United Kingdom
| $4 | – | – | – |
|
|
BCM
30
Bridgeway Capital Management
Houston,
Texas
| – | -$273K | -79,000 | Closed |
|
|
WIC
31
Woodmont Investment Counsel
Nashville,
Tennessee
| – | -$69K | -20,000 | Closed |
|
32
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$7K | -1,900 | Closed |
|
|
TRCT
33
Tower Research Capital (TRC)
New York
| – | -$4K | -1,033 | Closed |
|
34
JP Morgan Chase
New York
| – | -$2K | -600 | Closed |
|
35
Morgan Stanley
New York
| – | +$17 | +5 | New |
|
APEN Hedge Fund Activity: Q1 2019 in Review
31 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q1 2019, worth a combined $34.2M — up 15% from $29.7M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of APEN and 4 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 12 added.
The largest buyer was Stonepine Capital Management, adding an estimated $1.38M. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $273K sold.
- 31 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q1 2019, down from 35 in Q4 2018.
- Funds reported $34.2M of Apollo Endosurgery, Inc. stock for Q1 2019, up 15% quarter-over-quarter.
- 4 funds opened new Apollo Endosurgery, Inc. positions in Q1 2019 and 8 closed out, a net change of -4 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q1 2019 was Stonepine Capital Management, an estimated $1.38M added.
- The largest Apollo Endosurgery, Inc. seller in Q1 2019 was Bridgeway Capital Management, an estimated $273K sold.
Based on aggregated 13F filings for Q1 2019.